Services

Lab Professionals

Institutional Customers

About HUMAN

Jobs

Download center

search md icon
telegram icon Contact us sitemap icon Sitemap
  2. Reagents

Reagents

    451 Items are shown

    Rapid tests for the detection of syphilis. Hexagon Syphilis: Immunochromatographic rapid test Syphilis RPR: Rapid plasma reagin charcoal enhanced flocculation test Syphilis TPHA liquid: Hemagglutination test

    test

    Hemostat Thrombin Time is an assay for use on manual or fully automated coagulation instruments. It is a routine test suitable for monitoring fibrinolytic therapy, screening for disorders of fibrin formation and to monitor heparin therapy.
    Hemostat Thromboplastin-SI is a highly sensitive reagent intended for the manual and automated determination of prothrombin time (PT) in lyophilized format. Due to its factor sensitivity it can be used to assay the activity of coagulation factors in the extrinsic and common pathway of coagulation (factors II, V, VII, and X).
    Determination of antibodies to thyroglobulin
    Quantitative determination of antibodies to thyroperoxidase.
    Quantitative determination of Thyrotropin.
    The iron and total iron binding capacity (TIBC) levels are influenced by changes in iron intake, absorption, storage, and release mechanisms. Such changes are indicative of a wide range of dysfunctions including anemias, nephrosis, cirrhosis and hepatitis. Iron and TIBC measurements are interrelated parameters for the diagnosis of the iron status. Saturation and absorbant reagents for sample preparation for the determination of total iron binding capacity (TIBC) in human serum or heparinised plasma.
    Quantitative determination of total thyroxine (T4)
    Quantitative determination of total triiodothyronine (T3)
    Qualitative determination of IgG or IgM (μ-capture) antibodies to Toxoplasma gondii Remark: Toxo IgG (WHO calibration)
    Transferrin is the principle plasma protein for the transport of iron. Transferrin is a negative acute phase reactant and will decrease during any inflammatory state or malignancy. Increased levels of transferrin are found in iron deficiency, pregnancy, oestrogen administration and lipoidal nephrosis. Decreased levels may be encountered in hereditary deficiencies, testosterone administration, infection, acute inflammation, some forms of nephrosis, tumors, haemochromatosis, acute malaria and malnutrition. Immunoturbidimetric test for the quantitative determination of transferrin in human serum.
    The measurement of triglycerides (TG) is used for diagnosis of primary and secondary hyperlipoproteinemias, primary and secondary prevention of coronary vascular disease (CHD), risk marker of metabolic syndrom, LDL-c calculation using the Friedewald formula as well as control of dietary and medical lipid lowering. Enzymatic colorimetric test for the quantitative determination of triglycerides in human serum and plasma.
    Test for the triage of patients suspected for myocardial infarction in locations without access to particle-based chemiluminescent Troponin immunoassays. Immunochromatographic 1-step test for cardiac troponin I (cTnI). Detection limit: 0.5 ng/ml.
    Quantitative determination of antibodies to tissue transglutaminase.
    Qualitative test for the detection of bacteria belonging to Mycobacterium Tuberculosis Complex (MTBC). Storage and shipment at 2...30°C
    Quantitative / qualitative determination of IgG antibodies to U1-snRNP. Calibration: 12.5/25/50/100/200 U/ml Cut-off: 25 U/ml
    Urea (UREA, BUN) measurements are used in the diagnosis, differential diagnosis, assessment and therapy control of certain renal and metabolic diseases such as acute renal failure, terminal renal disease, and metabolic status of intensive care and dialysis patients. Urea and creatinine determinations are frequently performed together in the differential diagnosis of kidney function. Conversion factor for UREA, BUN [mg/dl] Conc. (UREA) = 2.14 x conc. (BUN); conc. (BUN) = 0.47 x conc. (UREA) Enzymatic colorimetric test and fully enzymatic UV test for the quantitative determination of urea in human serum, plasma and urine.
    Uric acid measurements are used in the diagnosis and therapy control of numerous renal and metabolic disorders, including chronic kidney disease, kidney stones, renal failure, gout, hyperlipidemia, leukemia, psoriasis, starvation or other wasting conditions and of patients receiving cytotoxic drugs or cyclosporine therapy in transplant recipients. Enzymatic colorimetric test with or without ascorbate oxidase for the quantitative determination of uric acid in human serum, plasma and urine.
    The determination of total protein in urine supports the diagnosis and treatment of primary and secondary kidney disease and the diagnosis of diseases associated with cardiac and thyroid function. Increased total protein concentration in the urine (proteinuria) is a very common urinary finding and is one of the leading symptoms of kidney disease in addition to reduced eGFR. Increased total protein concentrations in cerebrospinal fluid (CSF) are observed in a variety of disease states of the central nervous system (CNS), e.g. cerebral haemorrhage, bacterial or viral meningitis, inflammatory CNS disorders and tumors. Colorimetric test for the quantitative determination of total protein in human urine and cerebrospinal fluid (CSF).
    Qualitative determination of IgG or IgM antibodies to varicella-zoster virus
    Qualitative determination of vasculitis IgG antibodies. Internal function and cut-off control
    Quantitative determination of 25-OH vitamin D Remark: ID-LC / MS-MS calibration

    Need help finding instruments?

    We will gladly assist you in making the right decision to achieve your business goals

    message question circle icon Get a consultation
    Need help finding instruments?
    Loading…
    Loading the web debug toolbar…
    Attempt #